A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort.
<h4>Background</h4>Vitamin D deficiency is associated with reduced lung function. Cathelicidin, an antimicrobial peptide regulated by vitamin D, plays a role within the innate immune system. The association of cathelicidin with lung function decrement and respiratory infection is undefin...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5a90343c7c874585b8c51950618079b0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:5a90343c7c874585b8c51950618079b0 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:5a90343c7c874585b8c51950618079b02021-11-18T08:22:47ZA cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort.1932-620310.1371/journal.pone.0095099https://doaj.org/article/5a90343c7c874585b8c51950618079b02014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24743155/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Vitamin D deficiency is associated with reduced lung function. Cathelicidin, an antimicrobial peptide regulated by vitamin D, plays a role within the innate immune system. The association of cathelicidin with lung function decrement and respiratory infection is undefined. We determined the independent relationship of cathelicidin with lung function.<h4>Methods</h4>In a cross-sectional analysis of 650 participants in an urban observational cohort with high smoking prevalence, plasma 25(OH)-vitamin D and cathelicidin levels were measured from stored samples obtained within 6 months of spirometry study visits. Multivariable linear regression was used to determine the independent association between low cathelicidin (defined as the lowest quartile of the cohort) and absolute forced expiratory volume in 1 second (FEV1).<h4>Results</h4>The mean age of the cohort was 49 years; 91% were black, 35% female and 41% HIV-infected. Participants with low cathelicidin had a 183 mL lower FEV1 compared to higher cathelicidin (p = 0.009); this relationship was maintained (115 ml lower; p = 0.035) after adjusting for demographics, BMI, and smoking. Neither HIV serostatus, heavy smoking history, nor 25(OH)-vitamin D levels were associated with cathelicidin levels. Participants with low cathelicidin had a greater prevalence of prior bacterial pneumonia (21% versus 14%; p = 0.047). Inclusion of pneumonia in adjusted models did not substantially reduce the FEV1 decrement observed with low cathelicidin (104 mL lower FEV1; p = 0.05). Lung function decrements associated with low cathelicidin were greatest among individuals with lower 25(OH)-vitamin D levels.<h4>Conclusions</h4>In a cohort at risk for airflow obstruction, low cathelicidin was independently associated with lower FEV1. These clinical data support a mechanistic link between 25(OH)-vitamin D deficiency and lung function impairment, independent of pneumonia risk.Allison A LambertGregory D KirkJacquie AstemborskiEnid R NeptuneShruti H MehtaRobert A WiseM Bradley DrummondPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 4, p e95099 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Allison A Lambert Gregory D Kirk Jacquie Astemborski Enid R Neptune Shruti H Mehta Robert A Wise M Bradley Drummond A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort. |
| description |
<h4>Background</h4>Vitamin D deficiency is associated with reduced lung function. Cathelicidin, an antimicrobial peptide regulated by vitamin D, plays a role within the innate immune system. The association of cathelicidin with lung function decrement and respiratory infection is undefined. We determined the independent relationship of cathelicidin with lung function.<h4>Methods</h4>In a cross-sectional analysis of 650 participants in an urban observational cohort with high smoking prevalence, plasma 25(OH)-vitamin D and cathelicidin levels were measured from stored samples obtained within 6 months of spirometry study visits. Multivariable linear regression was used to determine the independent association between low cathelicidin (defined as the lowest quartile of the cohort) and absolute forced expiratory volume in 1 second (FEV1).<h4>Results</h4>The mean age of the cohort was 49 years; 91% were black, 35% female and 41% HIV-infected. Participants with low cathelicidin had a 183 mL lower FEV1 compared to higher cathelicidin (p = 0.009); this relationship was maintained (115 ml lower; p = 0.035) after adjusting for demographics, BMI, and smoking. Neither HIV serostatus, heavy smoking history, nor 25(OH)-vitamin D levels were associated with cathelicidin levels. Participants with low cathelicidin had a greater prevalence of prior bacterial pneumonia (21% versus 14%; p = 0.047). Inclusion of pneumonia in adjusted models did not substantially reduce the FEV1 decrement observed with low cathelicidin (104 mL lower FEV1; p = 0.05). Lung function decrements associated with low cathelicidin were greatest among individuals with lower 25(OH)-vitamin D levels.<h4>Conclusions</h4>In a cohort at risk for airflow obstruction, low cathelicidin was independently associated with lower FEV1. These clinical data support a mechanistic link between 25(OH)-vitamin D deficiency and lung function impairment, independent of pneumonia risk. |
| format |
article |
| author |
Allison A Lambert Gregory D Kirk Jacquie Astemborski Enid R Neptune Shruti H Mehta Robert A Wise M Bradley Drummond |
| author_facet |
Allison A Lambert Gregory D Kirk Jacquie Astemborski Enid R Neptune Shruti H Mehta Robert A Wise M Bradley Drummond |
| author_sort |
Allison A Lambert |
| title |
A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort. |
| title_short |
A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort. |
| title_full |
A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort. |
| title_fullStr |
A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort. |
| title_full_unstemmed |
A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort. |
| title_sort |
cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the alive cohort. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/5a90343c7c874585b8c51950618079b0 |
| work_keys_str_mv |
AT allisonalambert acrosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT gregorydkirk acrosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT jacquieastemborski acrosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT enidrneptune acrosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT shrutihmehta acrosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT robertawise acrosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT mbradleydrummond acrosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT allisonalambert crosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT gregorydkirk crosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT jacquieastemborski crosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT enidrneptune crosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT shrutihmehta crosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT robertawise crosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort AT mbradleydrummond crosssectionalanalysisoftheroleoftheantimicrobialpeptidecathelicidininlungfunctionimpairmentwithinthealivecohort |
| _version_ |
1718421862585729024 |